DALL-E (Discontinued) vs GPT-Rosalind (OpenAI)

Which one should you pick? Here's the full breakdown.

DALL-E (Discontinued)

D
5.0/10

OpenAI's DALL-E 2 and DALL-E 3 -- DEPRECATED. API shuts down May 12, 2026. DALL-E 3 already removed from ChatGPT in December 2025. See alternatives: Nano Banana 2, Midjourney, FLUX.2 [klein], Ideogram

Our Pick

GPT-Rosalind (OpenAI)

C
6.8/10

OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)

CategoryDALL-E (Discontinued)GPT-Rosalind (OpenAI)
Ease of Use9.03.0
Output Quality8.09.0
Value1.07.0
Features3.08.0
Overall5.06.8

Pricing Comparison

FeatureDALL-E (Discontinued)GPT-Rosalind (OpenAI)
Free TierNoNo
Starting PriceN/AInvite only

Which Should You Pick?

Pick DALL-E (Discontinued) if...

  • Easier to use (9 vs 3)

Historical context only. If you have an API integration with DALL-E, migrate before May 12, 2026. Choose from: GPT Image inside ChatGPT (direct replacement), Nano Banana 2 (best text-in-image), Midjourney (best artistic), FLUX.2 [klein] (best open-weight), or Ideogram (strong text).

Visit DALL-E (Discontinued)

Pick GPT-Rosalind (OpenAI) if...

  • Higher output quality (9 vs 8)
  • Better value for money (7/10)
  • More features (8 vs 3)

Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.

Visit GPT-Rosalind (OpenAI)

Our Verdict

GPT-Rosalind (OpenAI) is the clear winner here with 6.8/10 vs 5.0/10. DALL-E (Discontinued) isn't bad, but GPT-Rosalind (OpenAI) outperforms it across the board. Pick DALL-E (Discontinued) only if historical context only.